全膝关节置换术后持续性疼痛的生物学危险因素识别
这项前瞻性队列研究纳入162例因终末期骨关节炎行初次单侧全膝关节置换术的患者,旨在描述术后持续疼痛(PPP)患者围术期血浆和滑液的细胞因子谱。术后6个月PPP发生率为15/162(9.3%)。发生PPP的患者术后血浆IL-10、IL-1β、VEGF和IL12/IL23p40水平存在显著差异,且术前滑液IL-10水平较低与PPP发生相关。
要点
- 术后6个月PPP发生率为9.3%(15/162)。
- PPP患者术后血浆IL-10、IL-1β、VEGF和IL12/IL23p40水平显著不同。
- 术前滑液IL-10水平较低与术后持续疼痛相关。
核心结论
- 发生TKA术后持续疼痛的患者表现出独特的急性围术期炎症反应谱,其特征为术后前2天四种细胞因子存在显著差异。
- 结果支持患者对手术的特异性生物学反应可能影响TKA术后长期临床结局。
研究设计与样本
- 前瞻性队列研究,纳入因终末期骨关节炎行初次单侧TKA的患者。
- 术前和术后收集人口学与临床数据,术前关节切开前采集滑液,术前术后多个时间点采集血浆。
- 使用V-Plex Human Cytokine 30-Plex Panel(Mesoscale-Rockville, Maryland, USA)测量细胞因子水平。
- PPP定义为术后6个月数字评分量表(NRS)≥4分。
- 比较PPP组与轻微疼痛组的细胞因子水平,因研究为探索性未进行多重检验校正。
主要发现
- 术后6个月TKA后持续疼痛发生率为15/162(9.3%)。
- 发生持续术后疼痛的患者术后血浆四种细胞因子水平存在显著差异:白细胞介素(IL)-10、IL-1β、血管内皮生长因子(VEGF)和IL12/IL23p40。
- 关节切开前滑液中IL-10水平显著较低与术后持续疼痛的发生相关。
临床怎么用
- 围术期细胞因子谱(尤其是IL-10、IL-1β、VEGF和IL12/IL23p40)可能有助于识别TKA术后持续疼痛高风险患者。
- 术前滑液IL-10水平较低或可作为术后持续疼痛的预警指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is growing evidence that cytokines and adipokines are associated with osteoarthritis (OA) severity, progression, and severity of associated pain. However, the cytokine response to total knee arthroplasty (TKA) and its association with persistent postoperative pain is not well understood. This study aims to describe the perioperative systemic (plasma) and local (synovial fluid) cytokine profiles of patients who do and do not develop persistent pain after TKA. METHODS: Patients undergoing primary unilateral TKA for end-stage OA were prospectively enrolled. Demographic and clinical data were gathered preoperatively and postoperatively. Synovial fluid was collected pre arthrotomy and plasma was collected at multiple time points before and after surgery. Persistent postoperative pain (PPP) was defined as Numerical Rating Score≥4 at 6 months. Cytokine levels were measured using the V-Plex Human Cytokine 30-Plex Panel (Mesoscale-Rockville, Maryland, USA). Cytokine levels were compared between PPP and minimal pain groups. Given that the study outcomes are exploratory, no adjustment was performed for multiple testing. RESULTS: Incidence of persistent pain at 6 months post TKA was 15/162 (9.3%). Postoperative plasma levels of four cytokines were significantly different in patients who developed persistent postoperative pain: interleukin (IL)-10, IL-1β, vascular endothelial growth factor, and IL12/IL23p40. Significantly lower IL-10 levels in the prearthrotomy synovial fluid were associated with development of postoperative persistent pain. CONCLUSIONS: This prospective cohort study described a distinct acute perioperative inflammatory response profile in patients who developed persistent post-TKA pain, characterized by significant differences in four cytokines over the first 2 postoperative days. These results support the growing evidence that the patient-specific biologic response to surgery may influence longer-term clinical outcomes after TKA. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov NCT02626533.
引用
- Sideris A, Malahias MA, Birch G, et al. Identification of biological risk factors for persistent postoperative pain after total knee arthroplasty. Reg Anesth Pain Med. 2021. PMID: 34921052. doi:10.1136/rapm-2021-102953
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。